Health

Carrier Screening Market – 2022-2026 | Rising Prevalence of Genetic Diseases and Disorders to Boost Market Growth | 17,000+ Technavio Research Reports

NEW YORK, The “Carrier Screening Market by Type (Expanded carrier screening and Targeted disease carrier screening) and Geography (North America, Europe, Asia, and Rest of World (ROW)) – Forecast and Analysis 2022-2026” report has been added to Technavio’s offering. With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.

The potential growth difference for the carrier screening market from 2021 to 2026 is USD 2.36 billion. To get the exact yearly growth variance and the Y-O-Y growth rate, Talk to our analyst.

Key Market Dynamics:

Market DriverThe increased frequency of genetic illnesses and disorders such as cystic fibrosis, Tay-Sachs disease, and sickle cell anemia is one of the important reasons driving the worldwide carrier screening market growth. Prenatal testing has become more popular as the frequency of impairments in infants has increased, allowing doctors to swiftly treat treatable genetic abnormalities and diseases.According to the CDC, every year in the United States, one out of every 33 newborns (about 3%) is born with birth defects. Around the world, between 7 million and 9 million kids are born with birth disorders. Furthermore, parents with inheritable genetic illnesses such as autosomal dominant and recessive disorders prefer prenatal testing protocols for early disease detection.Market ChallengesOne of the significant carrier screening market trends that are projected to drive market expansion in the forecast period is the rising tendencies of next-generation sequencing (NGS) technology in carrier screening. NGS has advanced genetic research by allowing wide-scale sequencing of the human genome to find disease-causing mutations and gene variations of intermediate to large size.

The carrier screening market report is segmented by Type (Expanded carrier screening and Targeted disease carrier screening) and Geography (North America, Europe, Asia, and the Rest of the World (ROW)). North America will be the leading region with 37% of the market’s growth during the forecast period. The US, Germany, UK, Japan, and China are the key market for carrier screening in North America. Growing concerns on early disease diagnosis, a significant rise in commercial approvals for advanced carrier screening, and the increasing use of pharmacogenomic testing will facilitate the carrier screening market growth in North America over the forecast period.

The expanded carrier screening sector will gain a substantial amount of market share. Advancements in the extended carrier screening market, such as Sema4 Elements Expanded Carrier Screen (ECS) with Personalized Residual Risk solution from Sema4 OpCo, Inc, are likely to boost demand, resulting in segment growth throughout the projection period.
Some Companies Mentioned with their Offerings
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market. 
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
Abbott LaboratoriesAgilent Technologies Inc.CENTOGENE NVDanaher Corp.Eurofins Scientific SEDiaSorin SpAF. Hoffmann La Roche Ltd.Fulgent GeneticsGene By Gene LtdIllumina Inc.Invitae Corp.Laboratory Corp. of America HoldingsMedGenome Labs Ltd.Myriad Genetics Inc.Natera Inc.OPKO Health Inc.
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

This article was shared with Prittle Prattle News as a Press Release by PRNewswire.

Related Posts

1 of 849